Glaucocalyxin A Protects H9c2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of Akt/Nrf2/HO-1 Pathway.

In conclusion, these findings suggested that GLA protected H9c2 cells from H/R-stimulated oxidative damage, which was mediated by the Akt/Nrf2/HO-1 signaling pathway. Thus, GLA might be a promising therapeutic agent for the prevention and treatment of myocardial I/R.
PMID: 33172292 [PubMed - in process]

Source: Cell Transplantation - January 1, 2020 Category: Cytology Authors: Peng Z, Zhang R, Pan L, Pei H, Niu Z, Wang H, Lv J, Dang X Tags: Cell Transplant Source Type: research